• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Emergency

Outcomes similar for operative vs nonoperative treatment for acute unstable chest wall injuries

byMichael WongandAlex Chan
September 28, 2022
in Emergency, Surgery
Reading Time: 3 mins read
Standardized central line care practices reduce bloodstream infections
Share on FacebookShare on Twitter

1. In this randomized controlled trial, there was no significant difference in ventilator-free days (VFDs) in the first 28 days after injury in patients who received either operative or nonoperative treatment for an unstable chest wall injury.

2. In patients who were mechanically ventilated at the time of randomization, operative treatment resulted in a significantly shorter length of in-hospital stay versus nonoperative treatment.

Evidence Rating Level: 1 (Excellent)

Chest wall injuries causing instability from blunt chest trauma have high rates of mortality and morbidity; with high incidence of complications including chest wall instability and pulmonary complications. The most prevalent treatment is nonoperative, including intubation, positive pressure ventilation, pain control, and chest physiotherapy. However, this nonoperative approach may not produce optimal results. Previous research has reported improved outcomes with an operative versus nonoperative approach, but there is a paucity of high-quality randomized-controlled trials comparing these approaches. This multicenter, prospective, randomized controlled trial compared operative treatment of unstable chest wall injuries with nonoperative management. Patients were randomized to either receive operative or nonoperative treatment of their chest wall injury. The primary outcome was the number of ventilator-free days (VFDs) during the first 28 days following injury. 211 patients were recruited from 15 level 1 trauma centers across Canada and the United States from October 2011 to September 2018 meeting an indication for surgical fixation of chest wall injury. 111 patients were randomly assigned to receive operative treatment, and 100 patients were randomly assigned to receive nonoperative treatment. With respect to the primary outcome, mean VFDs were 22.7 days for the operative group, and 20.6 days for the nonoperative group (mean difference 2.1 days; 95% CI, -0.3 to 4.5 days; P=.09). However, in patients who were ventilated at the time of randomization, operative treatment reduced length of stay in hospital (HR, 1.4; 95% CI, 0.9 – 2.1) when compared to nonoperative treatment, while the number of VFDs were still similar between the two groups. There were no statistically significant differences between the two groups with respect to VFDs or number of days receiving mechanical ventilation. For secondary outcomes, there were no differences in length of hospital or ICU stay between groups, similar rates of complications, and rates of pneumonia, sepsis, and tracheostomy. A major limitation of this study was the sample size; though it was one of the largest randomized controlled trials to date of this type, it was underpowered to detect statistical significance in certain outcomes. Overall, the findings of this study suggest no difference in operative versus nonoperative treatment in patients with acute unstable chest wall injuries with respect to VFDs and complications. However, within the subgroup analyses, there was a possible benefit of operative treatment in patients receiving mechanical ventilation at the time of randomization, resulting in a significantly shorter in-hospital stay. Further investigation is required, particularly more randomized controlled trials, to adequately compare operative versus nonoperative treatment in acute unstable chest wall injuries.

Click to read the study in JAMA Surgery

Image: PD

RELATED REPORTS

Surgery is associated with an increased quality of life in women with endometriosis

Active surveillance is cost-effective compared with standard surgery among esophageal cancer patients with complete clinical response after neoadjuvant chemoradiotherapy

A robotic approach for ventral hernia repair may improve postoperative outcomes

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: Surgerytrauma
Previous Post

Linzagolix significantly reduces heavy menstrual bleeding in women with uterine fibroids

Next Post

#VisualAbstract: Treatment with adjuvant mFOLFIRINOX as compared with gemcitabine improves survival outcomes in resected pancreatic cancer

RelatedReports

Survival greater in cervical cancer patients undergoing abdominal hysterectomy compared to minimally invasive techniques: the LACC trial
Chronic Disease

Surgery is associated with an increased quality of life in women with endometriosis

August 11, 2026
Hybrid minimally invasive esophagectomy associated with lower complication rates compared to open esophagectomy
Chronic Disease

Active surveillance is cost-effective compared with standard surgery among esophageal cancer patients with complete clinical response after neoadjuvant chemoradiotherapy

August 6, 2026
Single-site robotic cholecystectomy is safe, but technically challenging
Gastroenterology

A robotic approach for ventral hernia repair may improve postoperative outcomes

May 4, 2026
Systematic review examines benefits and adverse effects of cannabinoid therapy
Weekly Rewinds

2 Minute Medicine Rewind May 4, 2026

May 4, 2026
Next Post
#VisualAbstract: Adjuvant pembrolizumab increased disease-free survival in completely resected, PD-L1 unselected non-small-cell lung cancer patients

#VisualAbstract: Treatment with adjuvant mFOLFIRINOX as compared with gemcitabine improves survival outcomes in resected pancreatic cancer

Mental health parity law associated with financial protection for children

Children who experience adversity have more police contact in adolescence

Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription

Perioperative gabapentin use associated with adverse outcomes for older adults

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Deep-learning model achieved high diagnostic performance for diabetic macular edema detection using optical coherence tomography (OCT) scans
  • FDA-cleared AI devices rarely have patient outcome data
  • Apixaban (Eliquis) is associated with reduced rates of ischemic stroke and bleeding in patients with atrial fibrillation and advanced chronic kidney disease compared with warfarin (Coumadin)
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.